Multiple Assemblies exist for SMTL entry 4wlb
Crystal structure of RORc in complex with a partial inverse agonist compound; X-RAY DIFFRACTION 1.70 Å

	SMTL ID 4wlb.1 Ligands SRC-1 peptide; N-(4-fluorobenzyl)-N-(2-methylpropyl)-6-{[1-(methylsulfonyl)piperidin-4-yl]amino}pyridine-3-sulfonamide; L(+)-TARTARIC ACID Polypeptides Nuclear receptor ROR-gamma Oligo-state homo-dimer
	SMTL ID 4wlb.2 Ligands SRC-1 peptide; N-(4-fluorobenzyl)-N-(2-methylpropyl)-6-{[1-(methylsulfonyl)piperidin-4-yl]amino}pyridine-3-sulfonamide; L(+)-TARTARIC ACID Polypeptides Nuclear receptor ROR-gamma Oligo-state homo-dimer
	SMTL ID 4wlb.3 Ligands SRC-1 peptide; N-(4-fluorobenzyl)-N-(2-methylpropyl)-6-{[1-(methylsulfonyl)piperidin-4-yl]amino}pyridine-3-sulfonamide; L(+)-TARTARIC ACID Polypeptides Nuclear receptor ROR-gamma Oligo-state monomer
	SMTL ID 4wlb.4 Ligands SRC-1 peptide; N-(4-fluorobenzyl)-N-(2-methylpropyl)-6-{[1-(methylsulfonyl)piperidin-4-yl]amino}pyridine-3-sulfonamide Polypeptides Nuclear receptor ROR-gamma Oligo-state monomer